Chinese
A Randomized, Double‐Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
Overview of attention for article published in Journal of Bone & Mineral Research, September 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (77th percentile)
-
Good Attention Score compared to outputs of the same age and source (78th percentile)
Readers on
- mendeley
- 165 Mendeley